314 related articles for article (PubMed ID: 34236105)
21. A novel small-molecule PI3K/Akt signaling inhibitor, W934, exhibits potent antitumor efficacy in A549 non-small-cell lung cancer.
Wang J; Wang HY; Shen Y; Liang D; Wang HY; Zhang SQ; Cao YX; Cao L
Anticancer Drugs; 2019 Oct; 30(9):900-908. PubMed ID: 30913062
[TBL] [Abstract][Full Text] [Related]
22. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
23. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
Jiang M; Zhou LY; Xu N; An Q
Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
[TBL] [Abstract][Full Text] [Related]
24. Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.
Dong H; Wang M; Chang C; Sun M; Yang F; Li L; Feng M; Zhang L; Li Q; Zhu Y; Qiao Y; Xie T; Chen J
Biochem Pharmacol; 2020 Dec; 182():114266. PubMed ID: 33035506
[TBL] [Abstract][Full Text] [Related]
25. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
[TBL] [Abstract][Full Text] [Related]
26. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
27. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
[TBL] [Abstract][Full Text] [Related]
28. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
29. Serine Protease from
Chen Y; Tang Y; Tang Y; Yang Z; Ding G
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31226829
[TBL] [Abstract][Full Text] [Related]
30. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
Li X; Liu H; Lv C; Du J; Lian F; Zhang S; Wang Z; Zeng Y
Biomed Res Int; 2022; 2022():9304552. PubMed ID: 35402614
[No Abstract] [Full Text] [Related]
31. Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis.
Su C; Zhang P; Liu J; Cao Y
Biomed Pharmacother; 2017 Apr; 88():521-528. PubMed ID: 28129624
[TBL] [Abstract][Full Text] [Related]
32. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
33. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
34. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
35. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
36. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
Chen X; Zhang W; Xu X
World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378
[TBL] [Abstract][Full Text] [Related]
37. Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma.
Liu YT; Hsieh MJ; Lin JT; Chen G; Lin CC; Lo YS; Chuang YC; Hsi YT; Chen MK; Chou MC
Biomed Pharmacother; 2019 Mar; 111():262-269. PubMed ID: 30590314
[TBL] [Abstract][Full Text] [Related]
38. Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway.
Liu Y; Xia XC; Meng LY; Wang Y; Li YM
Mol Med Rep; 2019 Aug; 20(2):1187-1195. PubMed ID: 31173235
[TBL] [Abstract][Full Text] [Related]
39. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
40. A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Wang S; Zhang Y; Ren T; Wu Q; Lu H; Qin X; Liu Y; Ding H; Zhao Q
Cell Death Dis; 2020 Jun; 11(6):491. PubMed ID: 32606352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
